Diaceutics PLC
DIUXFOTCHealthcare● Active
$2.00
+$0.00(+0.00%)
Market Cap$169258896
P/E Ratio—
52W High$2.51
52W Low$1.3672
Diaceutics PLC（DIUXF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · DIUXF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.10M | ($1.91M) | ($1.75M) | $0.72M | $0.56M |
| Depreciation & Amort. | $5.81M | $4.63M | $4.77M | $3.01M | $1.80M |
| Stock-Based Comp. | $0.00M | $1.02M | $0.45M | $0.54M | $0.37M |
| Change in Working Capital | ($4.51M) | ($1.30M) | ($1.54M) | ($0.33M) | ($1.66M) |
| Net Cash from Operations | $1.50M | $0.65M | $1.31M | $5.15M | $0.57M |
| Investing Activities | |||||
| Capital Expenditure | ($0.07M) | ($4.63M) | ($4.86M) | ($4.87M) | ($5.60M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($6.45M) | ($4.03M) | ($4.21M) | ($4.87M) | ($5.60M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | ($0.05M) | ($0.10M) | ($0.17M) |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | ($0.20M) | $0.00M | $0.00M | ($0.06M) |
| Net Cash from Financing | ($0.33M) | ($0.06M) | ($0.24M) | ($0.13M) | ($0.27M) |
| Free Cash Flow | |||||
| Free Cash Flow | $1.42M | ($3.98M) | ($3.54M) | $0.28M | ($5.03M) |
| FCF Margin %(computed) | 3.71% | -12.38% | -14.95% | 1.43% | -36.08% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · GBP · M
深入了解Diaceutics PLC
关于Diaceutics PLC（DIUXF）现金流量表
Diaceutics PLC 2025财年经营活动现金流$0.00B，自由现金流$0.00B（FCF利润率3.71%），资本支出($0.00B)。
常见问题
DIUXF · 4 问Diaceutics PLC 2025财年自由现金流$0.00B，同比up135.8%。
DIUXF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10